Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $5.38 --0%
EPS Growth %: -8.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -8.3%
Financial Fact:
Loss per common share - basic and diluted: -0.14
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- JPMorgan Downgrades Shenzhen Inovance Tech (300124:CH) to Neutral
- UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
